Featured News Image Featured News | Jul 1 2024 Wu Tsai Neurosciences Institute Molecular toolmakers share glimpses of the future of brain science At the 2024 Neuro-omics Symposium, early-stage research funded by Wu Tsai Neuro's Big Ideas in Neuroscience program revealed exciting progress at the intersection of genomics and AI Image Featured News | Jun 27 2024 Wu Tsai Neurosciences Institute The Worm Has Turned: DIY Lab Platform Evaluates New Molecules in Minutes New software developed by the NeuroPlant Big Ideas in Neuroscience initiative turns an ordinary flatbed scanner and collection of nematode worms into a DIY platform to sniff out beneficial and harmful plant-based molecules Image Featured News | Jun 20 2024 Wu Tsai Neurosciences Institute How a new kind of brain plasticity could help make sense of addiction This week, we talk with Michelle Monje and Rob Malenka about recent findings on the role of myelin plasticity in opioid addiction Image Featured News | Jun 7 2024 Wu Tsai Neurosciences Institute Koret Human Neurosciences Community Lab Announces Inaugural Pilot Grant Awards To advance neuroscience research using EEG and TMS technologies, the Koret Human Neurosciences Community Lab has awarded its inaugural Human Neuroscience Pilot Grants to ten innovative research projects. News Filter & Sort Sort by ThemeNeuroHealth News TypeResearch news Featured News Sort by Newest to oldest Oldest to newest Image Featured News | Jan 9 2023 Wu Tsai Neuro The rebirth of psychedelic medicine Researchers at the the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine. Image Research news | Aug 29 2018 Stanford Medicine - Scope Opioid system plays key role in ketamine’s antidepressant effects, Stanford stud... For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc Research news | May 22 2017 Stanford Medicine - Scope Stanford researcher explores use of ketamine to treat severe mental illness Stanford researcher Carolyn Rodriguez, MD, PhD, was the first to explore ketamine as a treatment for OCD.
Image Featured News | Jul 1 2024 Wu Tsai Neurosciences Institute Molecular toolmakers share glimpses of the future of brain science At the 2024 Neuro-omics Symposium, early-stage research funded by Wu Tsai Neuro's Big Ideas in Neuroscience program revealed exciting progress at the intersection of genomics and AI
Image Featured News | Jun 27 2024 Wu Tsai Neurosciences Institute The Worm Has Turned: DIY Lab Platform Evaluates New Molecules in Minutes New software developed by the NeuroPlant Big Ideas in Neuroscience initiative turns an ordinary flatbed scanner and collection of nematode worms into a DIY platform to sniff out beneficial and harmful plant-based molecules
Image Featured News | Jun 20 2024 Wu Tsai Neurosciences Institute How a new kind of brain plasticity could help make sense of addiction This week, we talk with Michelle Monje and Rob Malenka about recent findings on the role of myelin plasticity in opioid addiction
Image Featured News | Jun 7 2024 Wu Tsai Neurosciences Institute Koret Human Neurosciences Community Lab Announces Inaugural Pilot Grant Awards To advance neuroscience research using EEG and TMS technologies, the Koret Human Neurosciences Community Lab has awarded its inaugural Human Neuroscience Pilot Grants to ten innovative research projects.
Image Featured News | Jan 9 2023 Wu Tsai Neuro The rebirth of psychedelic medicine Researchers at the the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.
Image Research news | Aug 29 2018 Stanford Medicine - Scope Opioid system plays key role in ketamine’s antidepressant effects, Stanford stud... For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc
Research news | May 22 2017 Stanford Medicine - Scope Stanford researcher explores use of ketamine to treat severe mental illness Stanford researcher Carolyn Rodriguez, MD, PhD, was the first to explore ketamine as a treatment for OCD.